“a nonsignificant trend”

They were older (although with considerable overlap), did have a nonsignificant trend towards a worse PS ( p = 0.07) but substages were not different.

EnsoETM recipients showed a nonsignificant trend in taking longer to achieve NT than other TMDs (5.4 hours vs. 2.9 hours, p = 0.07).

In Cox regression analysis, a nonsignificant trend for visceral obesity was observed (HR: 0.62, 95% CI: 0.36–1.05, p = 0.07).

88.9 ± 12.2; p = 0.588) were comparable; Tegner showed a nonsignificant trend favoring PLT (5.9 ± 1.7 vs. 5.4 ± 1.7; p = 0.071).

In the adjusted model, diastolic blood pressure was positively associated with TSH [ β = 2.68 (0.27 to 5.09); p = 0.030]; left ventricle ejection fraction (LVEF) was negatively associated with FT4 [ β = -24.85 (-47.87 to -1.82); p = 0.035]; and a nonsignificant trend for a positive association was found between 30-day all-cause mortality and FT4 [OR = 3.40 (0.90 to 12.83); p = 0.071].

Stratified by treatment, patients with CK/MK receiving IC showed a nonsignificant trend toward improved survival vs inv(3)/t(3;3) receiving IC (mOS: 12 months [95% CI, 9.0-22] vs 10 months [95% CI, 5.6-35]; P = .071) ( Figure 5 B).

Edmondson–Steiner grade showed a nonsignificant trend toward higher recurrence risk (OR = 2.45; 95% CI 0.93–6.48; p = 0.071).

There was a nonsignificant trend for females in the UVA treatment to have lighter end weights than control females (df = 275, t = −1.816, P = 0.071).

There was a nonsignificant trend for more IPH in patients admitted with stroke compared to patients with TIA or patients with AFX (55.4% vs. 32.3% vs. 12.3%; p = 0.071) ( Table 1 ).

Within the esketamine-treated group, no predictors reached significance; baseline PHQ-9 severity showed a nonsignificant trend toward higher odds of response (OR = 1.24, 95% CI 0.98–1.57, p = 0.071).

Fisher's exact test (two-sided) indicated a nonsignificant trend toward a higher first-pass approval rate in the experimental group ( P = 0.071).

In the children with ADHD, task performance did not correlate with thickness of the pars opercularis (r = .201, n = 21, p = .383), whereas in the control group, there was a nonsignificant trend (r = .44, n = 18, p = .071).

TTVI was associated with a nonsignificant trend toward a lower incidence of all-cause mortality (risk ratio [RR]: 0.70, 95 % confidence interval [CI] 0.48–1.03; P = 0.071), primarily driven by observational studies.

The addition of metabolic biomarkers in Model 2 significantly improved model fit (adjusted R 2 = 0.213, p < 0.001), with TG emerging as a negative predictor of 6MWD (β = −0.33, p < 0.001), while FBG showed a nonsignificant trend (β = −0.34, p = 0.071).

There was a nonsignificant trend to those with cancer identified being less likely to be on a statin (14% vs 18%, P =0.071).

We observed a nonsignificant trend toward higher IgG levels ( P = 0.0712) and greater induction of TNF-α ( P = 0.0649) by serum PEG precipitates from RA patients compared with healthy control individuals (Figure 1a, b ).

CCL3 also showed a nonsignificant trend ( p = 0.0719).

There was a nonsignificant trend for Asian women to be more depressed than female Caucasians (51.1 vs 34.9%, P =0.072).

There was a nonsignificant trend toward a lower technical success rate in the transoral group (35/41 [85.4%, TO-WC] vs 75/79 [94.9%, EGD-WC], P = .072).

RESULTS LPS Increases Microglial Proinflammatory Gene Expression LPS significantly increased microglial proinflammatory gene expression in C3-C6 spinal segments 24 h after administration: IL6 (4.3-fold; P = 0.005), CD14 (7.7-fold; P < 0.001), and Ptgs2 (2.4-fold; P = 0.021); there was a nonsignificant trend toward increased IL1β (3-fold, P = 0.072; Fig. 2 ).

For the cuing effect on Δrecognition, number of spoken cues was the single strongest predictor; participants with >157 spoken cues had a nonsignificant trend for a positive cuing effect [mean = 0.37, SD = 0.27, t (3) = 2.73, p = 0.072], whereas those with fewer spoken cues had a negative cuing effect [mean = −0.22, SD = 0.42, t (18) = 2.29, p = 0.03].

We performed an exploratory post hoc analysis of ELA effects within each genotype and found a nonsignificant trend of ELA impact among AA carriers, F = 2.77, p = .072, and smaller differences for the AG and GG carrier groups.

48.5 months, adjusted HR 1.539, p = 0.003), while progression‐free survival (PFS) under PD‐1/PD‐L1 inhibitor therapy or chemoimmunotherapy showed a nonsignificant trend (7.1 vs. 13.0 months, adjusted HR 1.253, p = 0.072).

However, in multivariable Cox regression models adjusting for traditional cardiovascular risk factors, cfPWV showed a nonsignificant trend ( p = 0.072), while baPWV remained significantly associated with new‐onset events ( p < 0.001).

Astronauts with previous spaceflight experience demonstrated a nonsignificant trend towards being more likely to have a higher total microbleed count ( t 14 = 1.945, p = .072, d = 1.004), but no significant difference in simple microbleed presence ( t 14 = 0.764, p = .458, d = 0.524).